Patent number: 7354951
Abstract: The present invention relates to novel benzopyran ER-? agonist compounds, pharmaceutical compositions thereof, and use of these compounds to treat a ER-? mediated disease such as nocturia, obstructive uropathy, benign prostatic hypertrophy, obesity, dementia, hypertension, incontinence, colon cancer, prostate cancer, infertility, depression, leukemia, inflammatory bowel disease, and arthritis. Formula (I), wherein G is —O—, —S(O)n, —CF2—, —C(O)—, —CR1H— or —CR2(OH)—; R is halo, (C1-C4)alkyl or R3—(CH2)m—; R1 is F, hydroxyl, cyano, trifluoromethyl, (C1-C4)alkyl, (C2-C4)alkenyl, (C2-C4)alkynyl, (C1-C4)alkoxy, (C1-C4)alkylcarbonyloxy or benzyl; R2 is trifluoromethyl or (C1-C4)alkyl; R3 is cyano, hydroxyl, (C2-C4)alkenyl, (C1-C4)alkoxy or (C1-C4)alkoxycarbonyl; n is 0, 1 or 2; and m is 0, 1 or 2; and pharmaceutically acceptable salts thereof.
Type:
Grant
Filed:
October 5, 2005
Date of Patent:
April 8, 2008
Assignee:
Eli Lilly and Company
Inventors:
Bryan Hurst Norman, Timothy Ivo Richardson
Patent number: 7282246
Abstract: Concerning the compound of the formula (I) R1, R3 are each independently, for example, H R2, R4 are each independently, for example, H X1, X2 are each independently H or F M1 is —CO—O—, —O—CO—, —CH2—O—, —O—CH2—, —CF2—O—, —O—CF2—, —CH?CH—, —CF?CF—, —C?C—, —CH2—CH2—CO—O—, —O—CO—CH2—CH2—, —CH2—CH2—, —CF2—CF2—, —(CH2)4—, —OC(?O)CF?CF— or a single bond A1 is, for example, 1,4-phenylene, and R5 has the same possible definitions as specified for R2 and R4, with the exception of —M1-A1-R5, but independently of the particular definitions of R2 and R4 with the following provisos: 1) at least one of X1, X2 has to be F 2) R1, R2, R3 and R4 must not at the same time be H 3) at most two of R1, R2, R3 and R4 may be c).
Type:
Grant
Filed:
April 4, 2005
Date of Patent:
October 16, 2007
Assignee:
Merck Patent GmbH
Inventors:
Wolfgang Schmidt, Barbara Hornung, Rainer Wingen
Patent number: 6713622
Abstract: A set of 4,7-dichlororhodamine compounds useful as fluorescent dyes are disclosed having the structures
wherein R1-R6 are hydrogen, fluorine, chlorine, lower alkyl, lower alkene, lower alkyne, sulfonate, sulfone, amino, amido, nitrile, lower alkoxy, linking group, or, when taken together, R1 and R6 is benzo, or, when taken together, R4 and R5 is benzo; R7-R10, R12-R16 and R18 may be hydrogen, fluorine, chlorine, lower alkyl, lower alkene, lower alkyne, sulfonate, sulfone, amino, amido, nitrile, lower alkoxy, linking group; R11 and R17 may be hydrogen, lower alkyl, lower alkene, lower alkyne, phenyl, aryl, linking group; Y1-Y4 are hydrogen, lower alkyl, or cycloalkyl, or, when taken together, Y1 and R2, Y2 and R1 Y3 and R3, and/or Y4 and R4 is propano, ethano, or substituted forms thereof, and X1-X3 taken separately are hydrogen, chlorine, fluorine, lower alkyl, carboxylate, sulfonate, hydroxymethyl, and linking group, or any combinations thereof In another aspect, the invention includes reag
Type:
Grant
Filed:
May 25, 2000
Date of Patent:
March 30, 2004
Assignee:
Applera Corporation
Inventor:
Ronald J. Graham
© 2024 Justia
